Evidence map›Paper›PMID 40584607›Full record

ReviewCurrent medical mycology2024

Fatemeh Zahra Ranjbar Golafshani, Firoozeh Kermani, Soheila Abbaszadeh Godarzi, Mojtaba Taghizadeh Armaki, Saeid Mahdavi Omran

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current medical mycology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fatemeh Zahra Ranjbar GolafshaniDepartment of Parasitology and Medical Mycology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
Firoozeh KermaniDepartment of Parasitology and Medical Mycology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
Soheila Abbaszadeh GodarziDepartment of Obstetrics and Gynecology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
Mojtaba Taghizadeh ArmakiDepartment of Parasitology and Medical Mycology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
Saeid Mahdavi OmranDepartment of Parasitology and Medical Mycology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: Antifungal resistance in Materials and Methods: Under the PRISMA guidelines, a systematic review was conducted from January 2000 to December 2024, utilizing the articles from "Web of Sciences", "PubMed", and "Scopus". The search incorporated the terms Results: Three eligible studies reported an increase in the expression of the Conclusion: Review of the previous studies showed that the

Indexed as

Antifungal drug resistanceCandida glabrataNakaseomyces glabratusSystematic ReviewVulvovaginal candidiasis

Identifiers

PMID40584607
PMCPMC12205912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.